JP2005538125A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005538125A5 JP2005538125A5 JP2004526773A JP2004526773A JP2005538125A5 JP 2005538125 A5 JP2005538125 A5 JP 2005538125A5 JP 2004526773 A JP2004526773 A JP 2004526773A JP 2004526773 A JP2004526773 A JP 2004526773A JP 2005538125 A5 JP2005538125 A5 JP 2005538125A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkenyl
- hydroxy
- optionally substituted
- alkoxycarbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 62
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 17
- 125000003118 aryl group Chemical group 0.000 claims 16
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims 15
- 125000005090 alkenylcarbonyl group Chemical group 0.000 claims 14
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 14
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 13
- 125000003277 amino group Chemical group 0.000 claims 12
- -1 amino, piperidyl Chemical group 0.000 claims 12
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 11
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 11
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 11
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 11
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 9
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 8
- 125000004414 alkyl thio group Chemical group 0.000 claims 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 8
- 125000005843 halogen group Chemical group 0.000 claims 8
- 125000006574 non-aromatic ring group Chemical group 0.000 claims 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 8
- 229910005965 SO 2 Inorganic materials 0.000 claims 7
- 125000003342 alkenyl group Chemical group 0.000 claims 7
- 125000005137 alkenylsulfonyl group Chemical group 0.000 claims 7
- 125000004429 atom Chemical group 0.000 claims 7
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 3
- 125000004423 acyloxy group Chemical group 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 claims 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- 101100240517 Caenorhabditis elegans nhr-11 gene Proteins 0.000 claims 2
- 125000005035 acylthio group Chemical group 0.000 claims 2
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 2
- 150000001540 azides Chemical class 0.000 claims 2
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000005647 linker group Chemical group 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 125000003396 thiol group Chemical class [H]S* 0.000 claims 2
- UVAMIQMEQOXMSK-SHACYNPGSA-N (1r,4s)-1-hydroxy-n-(6-methoxy-1,5-naphthyridin-4-yl)-4-[(3-oxo-4h-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino]cyclohex-2-ene-1-carboxamide Chemical compound O1CC(=O)NC2=NC(CN[C@H]3CC[C@](C=C3)(O)C(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 UVAMIQMEQOXMSK-SHACYNPGSA-N 0.000 claims 1
- UYACEJSTFZKGCX-SHACYNPGSA-N (1r,4s)-1-hydroxy-n-(6-methoxy-1,5-naphthyridin-4-yl)-4-[(3-oxo-4h-pyrido[3,2-b][1,4]thiazin-6-yl)methylamino]cyclohex-2-ene-1-carboxamide Chemical compound S1CC(=O)NC2=NC(CN[C@H]3CC[C@](C=C3)(O)C(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 UYACEJSTFZKGCX-SHACYNPGSA-N 0.000 claims 1
- UVAMIQMEQOXMSK-LFPIHBKWSA-N (1s,4r)-1-hydroxy-n-(6-methoxy-1,5-naphthyridin-4-yl)-4-[(3-oxo-4h-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino]cyclohex-2-ene-1-carboxamide Chemical compound O1CC(=O)NC2=NC(CN[C@@H]3CC[C@@](C=C3)(O)C(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 UVAMIQMEQOXMSK-LFPIHBKWSA-N 0.000 claims 1
- UYACEJSTFZKGCX-LFPIHBKWSA-N (1s,4r)-1-hydroxy-n-(6-methoxy-1,5-naphthyridin-4-yl)-4-[(3-oxo-4h-pyrido[3,2-b][1,4]thiazin-6-yl)methylamino]cyclohex-2-ene-1-carboxamide Chemical compound S1CC(=O)NC2=NC(CN[C@@H]3CC[C@@](C=C3)(O)C(=O)NC3=CC=NC4=CC=C(N=C43)OC)=CC=C21 UYACEJSTFZKGCX-LFPIHBKWSA-N 0.000 claims 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 1
- 125000001414 1,2,4-triazol-5-yl group Chemical group [H]N1N=C([H])N=C1[*] 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 125000004442 acylamino group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 1
- 125000005189 alkyl hydroxy group Chemical group 0.000 claims 1
- 125000005360 alkyl sulfoxide group Chemical group 0.000 claims 1
- 125000005530 alkylenedioxy group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 1
- 125000005361 aryl sulfoxide group Chemical group 0.000 claims 1
- 125000005110 aryl thio group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 125000002527 bicyclic carbocyclic group Chemical group 0.000 claims 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims 1
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims 1
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims 1
- 125000004468 heterocyclylthio group Chemical group 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000005936 piperidyl group Chemical group 0.000 claims 1
- 125000006413 ring segment Chemical group 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0217294.8A GB0217294D0 (en) | 2002-07-25 | 2002-07-25 | Medicaments |
| PCT/EP2003/008153 WO2004014361A1 (en) | 2002-07-25 | 2003-07-23 | Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005538125A JP2005538125A (ja) | 2005-12-15 |
| JP2005538125A5 true JP2005538125A5 (enExample) | 2006-07-20 |
| JP4515260B2 JP4515260B2 (ja) | 2010-07-28 |
Family
ID=9941121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004526773A Expired - Fee Related JP4515260B2 (ja) | 2002-07-25 | 2003-07-23 | アミノシクロヘキセンキノリンおよび抗菌活性を有するそのアザアイソステリック類似体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060040925A1 (enExample) |
| EP (1) | EP1539133B1 (enExample) |
| JP (1) | JP4515260B2 (enExample) |
| AT (1) | ATE336995T1 (enExample) |
| AU (1) | AU2003251474A1 (enExample) |
| DE (1) | DE60307860T2 (enExample) |
| ES (1) | ES2270142T3 (enExample) |
| GB (1) | GB0217294D0 (enExample) |
| WO (1) | WO2004014361A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
| JP4445753B2 (ja) | 2002-01-29 | 2010-04-07 | グラクソ グループ リミテッド | アミノピペリジン誘導体 |
| EP1470131A2 (en) * | 2002-01-29 | 2004-10-27 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| AR040336A1 (es) * | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
| TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
| JP4654035B2 (ja) | 2002-11-05 | 2011-03-16 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 抗菌剤 |
| WO2004096982A2 (en) | 2002-11-05 | 2004-11-11 | Smithkline Beecham Corporation | Antibacterial agents |
| JP2006515862A (ja) | 2002-12-04 | 2006-06-08 | グラクソ グループ リミテッド | キノリン類およびそれらの窒素化誘導体ならびにそれらの抗菌剤としての使用 |
| TW200427688A (en) * | 2002-12-18 | 2004-12-16 | Glaxo Group Ltd | Antibacterial agents |
| JP2008502689A (ja) * | 2004-06-15 | 2008-01-31 | グラクソ グループ リミテッド | 抗菌剤 |
| US20080194547A1 (en) * | 2004-07-09 | 2008-08-14 | Glaxo Group Limited | Antibacterial Agents |
| MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
| WO2007086016A1 (en) | 2006-01-26 | 2007-08-02 | Actelion Pharmaceuticals Ltd | Tetrahydropyrane antibiotics |
| EP1991540A1 (en) * | 2006-02-21 | 2008-11-19 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| EP1991531A1 (en) * | 2006-02-28 | 2008-11-19 | Amgen Inc. | Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors |
| AU2007223801A1 (en) * | 2006-03-08 | 2007-09-13 | Amgen Inc. | Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
| JP2009532504A (ja) | 2006-04-06 | 2009-09-10 | グラクソ グループ リミテッド | 抗菌薬 |
| US7709483B2 (en) | 2006-04-06 | 2010-05-04 | Glaxo Group Limited | Pyrrolo-quinoxalinone derivatives as antibacterials |
| GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
| EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
| TW200819457A (en) | 2006-08-30 | 2008-05-01 | Actelion Pharmaceuticals Ltd | Spiro antibiotic derivatives |
| EP2137196B1 (en) * | 2007-04-20 | 2010-10-06 | Glaxo Group Limited | Tricyclic nitrogen containing compounds as antibacterial agents |
| EP2080761A1 (en) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Compounds |
| US20110275661A1 (en) | 2008-10-17 | 2011-11-10 | Glaxo Group Limited | Tricyclic nitrogen compounds used as antibacterials |
| ES2561631T3 (es) | 2009-01-15 | 2016-02-29 | Glaxo Group Limited | Compuestos de naftiridin-2(1H)-ona útiles como agentes antibacterianos |
| AR089929A1 (es) | 2012-02-10 | 2014-10-01 | Actelion Pharmaceuticals Ltd | Proceso para manufacturar un derivado de naftiridina |
| BR112015002493A8 (pt) * | 2012-08-30 | 2019-07-30 | Hoffmann La Roche | composto, composição farmacêutica, processo para a preparação de uma composição farmacêutica, kit e uso de um composto” |
| EP3182973B1 (en) | 2014-08-22 | 2019-09-18 | GlaxoSmithKline Intellectual Property Development Limited | Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection |
| TW201718514A (zh) | 2015-08-07 | 2017-06-01 | 拜耳作物科學股份有限公司 | 作為殺蟲劑之經２－（雜）芳基取代之稠合雜環衍生物 |
| TW201722965A (zh) | 2015-08-16 | 2017-07-01 | 葛蘭素史密斯克藍智慧財產發展有限公司 | 用於抗菌應用之化合物 |
| EP4045485A1 (en) | 2019-10-18 | 2022-08-24 | The Regents Of The University Of California | 3-phenylsulphonyl-quinoline derivatives as agents for treating pathogenic blood vessels disorders |
| CN119161260A (zh) * | 2024-06-26 | 2024-12-20 | 安徽大学 | 一种1-（2-氨基-4-氟-5-甲氧基苯基）-1-丙酮的合成方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0790981B1 (en) * | 1994-11-10 | 1999-09-08 | Pfizer Inc. | Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors |
| ES2201674T3 (es) * | 1998-01-26 | 2004-03-16 | Smithkline Beecham Plc | Derivados de quinolina con propiedades antibacterianas. |
| GB9822450D0 (en) * | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
| AU2437900A (en) * | 1999-01-20 | 2000-08-07 | Smithkline Beecham Plc | Piperidinylquinolines as protein tyrosine kinase inhibitors |
| GB9914486D0 (en) * | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
| GB9917406D0 (en) * | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| GB9917408D0 (en) * | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| PL366335A1 (en) * | 2000-07-26 | 2005-01-24 | Smithkline Beecham P.L.C. | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| FR2816618B1 (fr) * | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent |
| GB0031088D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
| GB0101577D0 (en) * | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
-
2002
- 2002-07-25 GB GBGB0217294.8A patent/GB0217294D0/en not_active Ceased
-
2003
- 2003-07-23 WO PCT/EP2003/008153 patent/WO2004014361A1/en not_active Ceased
- 2003-07-23 AU AU2003251474A patent/AU2003251474A1/en not_active Abandoned
- 2003-07-23 EP EP03784064A patent/EP1539133B1/en not_active Expired - Lifetime
- 2003-07-23 DE DE60307860T patent/DE60307860T2/de not_active Expired - Lifetime
- 2003-07-23 AT AT03784064T patent/ATE336995T1/de not_active IP Right Cessation
- 2003-07-23 US US10/522,058 patent/US20060040925A1/en not_active Abandoned
- 2003-07-23 JP JP2004526773A patent/JP4515260B2/ja not_active Expired - Fee Related
- 2003-07-23 ES ES03784064T patent/ES2270142T3/es not_active Expired - Lifetime